CNSP
CNS Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
2.19 / 10
Underperform
CNSP's fundamental status is unfavorable (2.2/10). Key positives include a healthy inventory turnover ratio (53.31) and strong interest coverage (66.19%), yet these are outweighed by subpar revenue growth and profit margin trends. The company's total operating revenue grew 105.85% YoY, but this high figure masks underlying execution risks. Net profit as a percentage of total profit is 100%, suggesting limited earnings quality. Overall, prudent capital allocation and clearer earnings visibility are needed to improve the fundamental outlook.
Analysis Checks(5/5)
Total operating revenue (YoY growth rate %)
Value105.85
Score3/3
Weight-38.74%
1M Return0.88%
Value105.85
Score3/3
Weight-38.74%
1M Return0.88%
Interest coverage ratio (EBIT / Interest expense) (%)
Value66.19
Score2/3
Weight52.06%
1M Return-1.25%
Value66.19
Score2/3
Weight52.06%
1M Return-1.25%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight41.10%
1M Return-0.98%
Value100.00
Score2/3
Weight41.10%
1M Return-0.98%
Inventory turnover ratio
Value53.31
Score2/3
Weight49.98%
1M Return-1.23%
Value53.31
Score2/3
Weight49.98%
1M Return-1.23%
Operating revenue (YoY growth rate %)
Value138.12
Score2/3
Weight-4.39%
1M Return0.10%
Value138.12
Score2/3
Weight-4.39%
1M Return0.10%
Total operating revenue (YoY growth rate %)
Value105.85
Score3/3
Weight-38.74%
1M Return0.88%
Value105.85
Score3/3
Weight-38.74%
1M Return0.88%
Inventory turnover ratio
Value53.31
Score2/3
Weight49.98%
1M Return-1.23%
Value53.31
Score2/3
Weight49.98%
1M Return-1.23%
Interest coverage ratio (EBIT / Interest expense) (%)
Value66.19
Score2/3
Weight52.06%
1M Return-1.25%
Value66.19
Score2/3
Weight52.06%
1M Return-1.25%
Operating revenue (YoY growth rate %)
Value138.12
Score2/3
Weight-4.39%
1M Return0.10%
Value138.12
Score2/3
Weight-4.39%
1M Return0.10%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight41.10%
1M Return-0.98%
Value100.00
Score2/3
Weight41.10%
1M Return-0.98%
Is CNSP undervalued or overvalued?
- CNSP scores 2.19/10 on fundamentals and holds a Premium valuation at present. Backed by its -123.02% ROE, 0.00% net margin, -0.18 P/E ratio, 0.28 P/B ratio, and 101.47% earnings growth, these metrics solidify its Underperform investment rating.
